We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXU.U
12476
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
$127K ﹤0.01%
12,364
-482,744
-98% -$4.87M
DCRNU
12477
DELISTED
Decarbonization Plus Acquisition Corporation II Unit
DCRNU
$127K ﹤0.01%
+12,334
New +$127K
BSN.U
12478
DELISTED
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
$127K ﹤0.01%
12,110
-845
-7% -$8.79K
SWBK.U
12479
DELISTED
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
$127K ﹤0.01%
12,496
+342
+3% +$3.48K
GTE icon
12480
PUT
Gran Tierra Energy
GTE
$325M
$126K ﹤0.01%
17,060
-950
-5% -$5.73K
UBX
12481
PUT
DELISTED
Unity Biotechnology
UBX
$126K ﹤0.01%
4,190
-1,040
-20% -$36.7K
TTOO
12482
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$126K ﹤0.01%
28
-3
-10% -$15.1K
LDHAU
12483
DELISTED
LDH Growth Corp I Units
LDHAU
$126K ﹤0.01%
12,815
-100,909
-89% -$1M
SMED
12484
PUT
DELISTED
Sharps Compliance Corp
SMED
$126K ﹤0.01%
15,200
+100
+0.7% +$930
GTYH
12485
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$126K ﹤0.01%
16,801
-6,929
-29% -$49.7K
STEX
12486
Streamex Corp
STEX
$108M
$125K ﹤0.01%
+4,191
New +$136K
DHC
12487
CALL
Diversified Healthcare Trust
DHC
$2.03B
$125K ﹤0.01%
36,800
+21,700
+144% +$81.8K
SY
12488
CALL
So-Young International
SY
$225M
$125K ﹤0.01%
29,400
+2,500
+9% +$16.2K
VRNA
12489
DELISTED
Verona Pharma
VRNA
$125K ﹤0.01%
+22,870
New +$133K
GENE
12490
DELISTED
Genetic Technologies Ltd.
GENE
$125K ﹤0.01%
8,094
+2,724
+51% +$46.7K
VHAQ
12491
DELISTED
Viveon Health Acquisition Corp.
VHAQ
$125K ﹤0.01%
+12,492
New +$124K
DOMA
12492
PUT
DELISTED
Doma Holdings, Inc.
DOMA
$125K ﹤0.01%
+676
New +$142K
LHDX
12493
CALL
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$125K ﹤0.01%
+16,500
New +$139K
ACII.U
12494
DELISTED
Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant
ACII.U
$125K ﹤0.01%
12,526
-322,442
-96% -$3.22M
TINV.U
12495
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
$125K ﹤0.01%
12,012
-506
-4% -$5.29K
ATRS
12496
PUT
DELISTED
Antares Pharma, Inc.
ATRS
$125K ﹤0.01%
34,400
-21,000
-38% -$84.9K
CO
12497
DELISTED
Global Cord Blood Corporation
CO
$125K ﹤0.01%
26,790
-9,804
-27% -$48.1K
RNWK
12498
PUT
DELISTED
RealNetworks Inc
RNWK
$125K ﹤0.01%
78,700
-13,400
-15% -$24.6K
ARAY icon
12499
Accuray
ARAY
$33.2M
$124K ﹤0.01%
31,358
-62,506
-67% -$248K
ATEC icon
12500
PUT
Alphatec Holdings
ATEC
$1.51B
$124K ﹤0.01%
10,200
-15,500
-60% -$216K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.